Story perspectives

FDA Approves GlutenID Test for Celiac Risk Assessment

2/18/2025

32 3

Summary

Story summary

Targeted Genomics LLC has achieved a significant milestone with FDA 510(k) clearance for its innovative GlutenID test, designed to analyze genetic markers associated with celiac disease. By using simple saliva samples, the test offers personalized risk assessments, empowering users to make informed decisions about their health. However, consulting healthcare providers before making dietary changes is strongly recommended. GlutenID is now available for purchase online, opening new doors for those seeking clarity on their gluten sensitivity.

1 of 1

Story summary

Targeted Genomics LLC has achieved a significant milestone with FDA 510(k) clearance for its innovative GlutenID test, designed to analyze genetic markers associated with celiac disease. By using simple saliva samples, the test offers personalized risk assessments, empowering users to make informed decisions about their health. However, consulting healthcare providers before making dietary changes is strongly recommended. GlutenID is now available for purchase online, opening new doors for those seeking clarity on their gluten sensitivity.